Ranibizumab with photodynamic therapy in the treatment of wAMD

Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 11, Issue 6

Abstract

AIM: To investigate the clinical effect of Ranibizumab combined with photodynamic therapy(PDT)for wet type age-related macular degeneration(wAMD)and the effect on the serum neovascularization factors. <p>METHODS: Totally 68 cases(68 eyes)of wAMD patients treated with PDT in our hospital from January 2014 to June 2016 were analyzed retrospectively. Among them, 34 patients were treated by photodynamic therapy(control group)and 34 patients were treated by combination of photodynamic therapy and ranibizumab(treatment group). Comparison of BCVA, mean retinal thickness and central macular thickness(CMT)and serum neovascularization regulatory factors before and after treatment were taken between the two groups. <p>RESULTS: Before treatment, there was no significant difference on the BCVA, the average retinal thickness and the CMT value between the two groups(<i>P</i>>0.05). At 3, 6 and 12mo after treatment, the BCVA, average retinal thickness and CMT in both groups were significantly lower than those before treatment(<i>P</i><0.05). At 3, 6 and 12mo after treatment, the BCVA, the average retinal thickness and the CMT value of the patients in the treatment group were significantly lower than those in the control group(<i>P</i><0.05). There was no significant difference of vascular endothelial growth factor(VEGF), platelet derived growth factor(PDGF), matrix metallo-proteinase inhibitor(TIMP)-1 and endostatin(ES)between the two groups before treatment(<i>P</i>>0.05). Three months after treatment, VEGF, PDGF and ES in both groups were significantly lower than those before treatment(<i>P</i><0.05). Three months after treatment, the levels of VEGF, PDGF and ES in the treatment group were significantly lower than those in the control group(<i>P</i><0.05). <p>CONCLUSION: The wAMD patients treated with ranibizumab combined with photodynamic therapy can achieve a more significant clinical effect, and more effectively reduce the level of serum neovascularization regulators.

Authors and Affiliations

Guang - Ming Wan

Keywords

Related Articles

Progress of corneal biomechanical measurements and applications in clinic

Cornea is an important part ofhuman's refractive system. Corneal biomechanics plays an important role in corneal ectasia and related diseases. The corneal biomechanics measured <i>in vitro</i> and <i>in vivo</i> and its...

Effect of pterygium transplantation combined with amniotic membrane transplantation plus bandage contact lenses for pterygium

AIM: To investigate the effect of pterygium transplantation combined with amniotic membrane transplantation plus bandage type contact lenses. <p>METHODS: Totally 72 patients(80 eyes)with pterygium treated in our hospital...

Two kinds of goniosynechialysis for primary acute angle-closure glaucoma with cataract

AIM: To study the effect of two kinds of phacoemulsification combined with goniosynechialysis for primary angle-closure glaucoma with cataract. <p>METHODS: Phacoemulsification combined with goniosynechialysis was perform...

Clinical features and progress of surgical therapy for polypoidal choroidal vasculopathy

Polypoidal choroidal vasculopathy(PCV)is a fundus disease characterized by choroidal anomalous branch vascular network and terminal polypoidal dilatation. Submacular hemorrhages(SMH)and vitreous hemorrhage are devastatin...

Efficacy of fundus photocoagulation combined with triamcinolone acetonide on diabetic retinopathy

AIM: To observe the efficacy of fundus photocoagulation combined with triamcinolone acetonide(TA)in the treatment of diabetic retinopathy(DR). <p>METHODS: The clinical data of 94 patients(112 eyes)in our hospital from Se...

Download PDF file
  • EP ID EP562977
  • DOI 10.3980/j.issn.1672-5123.2018.6.34
  • Views 98
  • Downloads 0

How To Cite

Guang - Ming Wan (2018). Ranibizumab with photodynamic therapy in the treatment of wAMD. Guoji Yanke Zazhi, 11(6), -. https://europub.co.uk/articles/-A-562977